Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

European MAA submission for clofarabine for pediatric leukemias

Aug. 24, 2004

Canadian approval for phase I study of Proxinium

Aug. 24, 2004

Alimta approved for second-line treatment of advanced lung cancer

Aug. 24, 2004

ProIX obtains development and marketing rights for novel PI-3K inhibitors

Aug. 24, 2004

A cyanoguanidine-based prodrug identified as a clinical candidate by Leo scientists

Aug. 24, 2004

Protox Therapeutics retains CTBR for preclinical testing of PSA-PA1

Aug. 23, 2004

Viventia Biotech and Acceptys enter option agreement for anticancer antibodies

Aug. 23, 2004

Taxotere approved for early-stage breast cancer

Aug. 23, 2004

New phase I/II study of CG-7870 plus Taxotere for prostate cancer

Aug. 23, 2004

New EGFR inhibitors identified by Ariad scientists

Aug. 23, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...